Recruiting NA INTERVENTIONAL 2-arm NCT07271043

Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics

Evaluating the Efficacy of High-Protein Diabetes Specific Formula (HP-DSF) on Body Composition in Overweight/Obese Patients With Type 2 Diabetes Treated With Incretin Mimetic Drugs

Sponsor: Abbott

Conditions Type 2 Diabetes

Interventions protein supplement

Updated 2 times since 2026 Last updated: Jan 28, 2026 Started: Jan 1, 2026 Primary completion: Nov 1, 2026 Completion: Dec 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type 2 Diabetes and is currently actively recruiting participants. Abbott leads this study, which shows 2 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

2 versions recorded

Feb 2026 — Present [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jan 2026 — Feb 2026 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Joslin Diabetes Center

Data source: Joslin Diabetes Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States